Pragna Pharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 3.00 Cr
as on 23-10-2024
- Company Age 12 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 25.07 Cr
as on 23-10-2024
- Satisfied Charges ₹ 11.98 Cr
as on 23-10-2024
- Revenue -17.66%
(FY 2023)
- Profit -66.66%
(FY 2023)
- Ebitda -57.24%
(FY 2023)
- Net Worth 10.23%
(FY 2023)
- Total Assets 4.18%
(FY 2023)
About Pragna Pharma
The Corporate was formerly known as Shree Avani Chem Industries Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹25.07 Cr. The company has closed loans amounting to ₹11.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jigneshkumar Patel, Dipakkumar Patel, and Rakeshkumar Kothiya serve as directors at the Company.
- CIN/LLPIN
U24110GJ2012PTC068475
- Company No.
068475
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jan 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Bharuch, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pragna Pharma?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jigneshkumar Patel | Director | 16-May-2016 | Current |
Dipakkumar Patel | Director | 16-May-2016 | Current |
Rakeshkumar Kothiya | Director | 01-Jul-2021 | Current |
Financial Performance of Pragna Pharma.
Pragna Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.66% decrease. The company also saw a substantial fall in profitability, with a 66.66% decrease in profit. The company's net worth Soared by an impressive increase of 10.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Pragna Pharma?
In 2023, Pragna Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Pragna Speciality Private LimitedActive 3 years 9 months
Jigneshkumar Patel and Dipakkumar Patel are mutual person
- Pragna Life Science Private LimitedActive 12 years 5 months
Jigneshkumar Patel and Dipakkumar Patel are mutual person
- Bhavik Chem Private LimitedActive 12 years 11 months
Jigneshkumar Patel and Dipakkumar Patel are mutual person
- Pragna Fine Chem Private LimitedActive 4 years 6 months
Jigneshkumar Patel and Dipakkumar Patel are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Hdfc Bank Limited Creation Date: 11 Sep 2024 | ₹0.65 M | Open |
Others Creation Date: 01 May 2024 | ₹10.00 Cr | Open |
Others Creation Date: 01 May 2024 | ₹15.00 Cr | Open |
How Many Employees Work at Pragna Pharma?
Pragna Pharma has a workforce of 227 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pragna Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pragna Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.